| Bioactivity | GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhibitor 11 can be used in neurodegenerative disease research[1]. | |||||||||
| Name | GSK-3β inhibitor 11 | |||||||||
| CAS | 536731-65-4 | |||||||||
| Formula | C20H15N3O4S | |||||||||
| Molar Mass | 393.42 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Fu G, et al. Pharmacophore Modeling, Ensemble Docking, Virtual Screening, and Biological Evaluation on Glycogen Synthase Kinase-3β. Mol Inform. 2014 Sep;33(9):610-26. |
GSK-3β inhibitor 11
CAS: 536731-65-4 F: C20H15N3O4S W: 393.42
GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.